Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter March 15, 2007

The CFTR-derived peptides as a model of sequence-specific protein aggregation

Daniel Bąk, Garry Cutting and Michał Milewski

Abstract

Protein aggregation is a hallmark of a growing group of pathologies known as conformational diseases. Although many native or mutated proteins are able to form aggregates, the exact amino acid sequences involved in the process of aggregation are known only in a few cases. Hence, there is a need for different model systems to expand our knowledge in this area. The so-called ag region was previously found to cause the aggregation of the C-terminal fragment of the cystic fibrosis transmembrane conductance regulator (CFTR). To investigate whether this specific amino acid sequence is able to induce protein aggregation irrespective of the amino acid context, we altered its position within the CFTR-derived C-terminal peptide and analyzed the localization of such modified peptides in transfected mammalian cells. Insertion of the ag region into a different amino acid background affected not only the overall level of intracellular protein aggregation, but also the morphology and subcellular localization of aggregates, suggesting that sequences other than the ag region can substantially influence the peptide’s behavior. Also, the introduction of a short dipeptide (His-Arg) motif, a crucial component of the ag region, into different locations within the C-terminus of CFTR lead to changes in the aggregation pattern that were less striking, although still statistically significant. Thus, our results indicate that even subtle alterations within the aggregating peptide can affect many different aspects of the aggregation process.

[1] Carrell, R.W. and Lomas, D.A. Conformational disease. Lancet 350 (1997) 134–138. http://dx.doi.org/10.1016/S0140-6736(97)02073-410.1016/S0140-6736(97)02073-4Search in Google Scholar

[2] Kisilevsky, R. and Fraser, P.E. A beta amyloidogenesis: unique, or variation on a systemic theme? Crit. Rev. Biochem. Mol. Biol. 32 (1997) 361–404. 10.3109/10409239709082674Search in Google Scholar

[3] Kopito, R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10 (2000) 524–530. http://dx.doi.org/10.1016/S0962-8924(00)01852-310.1016/S0962-8924(00)01852-3Search in Google Scholar

[4] Donaldson, K.M., Li, W., Ching, K.A., Batalov, S., Tsai, C.C. and Joazeiro C.A. Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc. Natl. Acad. Sci. USA 100 (2003) 8892–8897. http://dx.doi.org/10.1073/pnas.153021210010.1073/pnas.1530212100Search in Google Scholar PubMed PubMed Central

[5] Kazantsev, A., Preisinger, E., Dranovsky, A., Goldgaber, D. and Housman, D. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc. Natl. Acad. Sci. USA 96 (1999) 11404–11409. http://dx.doi.org/10.1073/pnas.96.20.1140410.1073/pnas.96.20.11404Search in Google Scholar PubMed PubMed Central

[6] Preisinger, E., Jordan, B.M., Kazantsev, A. and Housman, D. Evidence for a recruitment and sequestration mechanism in Huntington’s disease. Philos. Trans. R. Soc. Lond B Biol. Sci. 354 (1999) 1029–1034. http://dx.doi.org/10.1098/rstb.1999.045510.1098/rstb.1999.0455Search in Google Scholar PubMed PubMed Central

[7] Schaffar, G., Breuer, P., Boteva, R., Behrends, C., Tzvetkov, N., Strippel, N., Sakahira, H., Siegers, K., Hayer-Hartl, M. and Hartl, F.U. Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol. Cell. 15 (2004) 95–105. http://dx.doi.org/10.1016/j.molcel.2004.06.02910.1016/j.molcel.2004.06.029Search in Google Scholar PubMed

[8] Suhr, S.T., Senut, M.C., Whitelegge, J.P., Faull, K.F., Cuizon, D.B. and Gage, F.H. Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. J. Cell Biol. 153 (2001) 283–294. http://dx.doi.org/10.1083/jcb.153.2.28310.1083/jcb.153.2.283Search in Google Scholar PubMed PubMed Central

[9] Stenoien, D.L., Cummings, C.J., Adams, H.P., Mancini, M.G., Patel, K., DeMartino, G.N., Marcelli, M., Weigel, N.L. and Mancini, M.A. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum. Mol. Genet. 8 (1999) 731–741. http://dx.doi.org/10.1093/hmg/8.5.73110.1093/hmg/8.5.731Search in Google Scholar PubMed

[10] Chai, Y., Wu, L., Griffin, J.D. and Paulson, H.L. The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease. J. Biol. Chem. 276 (2001) 44889–44897. http://dx.doi.org/10.1074/jbc.M10657520010.1074/jbc.M106575200Search in Google Scholar PubMed

[11] Nozaki, K., Onodera, O., Takano, H. and Tsuji, S. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation. Neuroreport 12 (2001) 3357–3364. http://dx.doi.org/10.1097/00001756-200110290-0004210.1097/00001756-200110290-00042Search in Google Scholar

[12] DiFiglia, M. Huntingtin fragments that aggregate go their separate ways. Mol. Cell. 10 (2002) 224–225. http://dx.doi.org/10.1016/S1097-2765(02)00609-310.1016/S1097-2765(02)00609-3Search in Google Scholar

[13] Ziegler, J., Viehrig, C., Geimer, S., Rosch, P. and Schwarzinger, S. Putative aggregation initiation sites in prion protein. FEBS Lett. 580 (2006) 2033–2040. http://dx.doi.org/10.1016/j.febslet.2006.03.00210.1016/j.febslet.2006.03.002Search in Google Scholar PubMed

[14] Gautreau, A., Fievet, B.T., Brault, E., Antony, C., Houdusse, A., Louvard, D. and Arpin, M. Isolation and characterization of an aggresome determinant in the NF2 tumor suppressor. J. Biol. Chem. 278 (2003) 6235–6242. http://dx.doi.org/10.1074/jbc.M21063920010.1074/jbc.M210639200Search in Google Scholar PubMed

[15] Link, C.D., Fonte, V., Hiester, B., Yerg, J., Ferguson, J., Csontos, S., Silverman, M.A. and Stein, G.H. Conversion of green fluorescent protein into a toxic, aggregation-prone protein by C-terminal addition of a short peptide. J. Biol. Chem. 281 (2006) 1808–1816. http://dx.doi.org/10.1074/jbc.M50558120010.1074/jbc.M505581200Search in Google Scholar PubMed

[16] Giasson, B.I., Murray, I.V., Trojanowski, J.Q. and Lee, V.M. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein isessential for filament assembly. J. Biol. Chem. 276 (2001) 2380–2386. http://dx.doi.org/10.1074/jbc.M00891920010.1074/jbc.M008919200Search in Google Scholar PubMed

[17] Johnston, J.A., Ward, C.L. and Kopito, R.R. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143 (1998) 1883–1898. http://dx.doi.org/10.1083/jcb.143.7.188310.1083/jcb.143.7.1883Search in Google Scholar PubMed PubMed Central

[18] Bence, N.F., Sampat, R.M. and Kopito, R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292 (2001) 1552–1555. http://dx.doi.org/10.1126/science.292.5521.155210.1126/science.292.5521.1552Search in Google Scholar PubMed

[19] Rajan, R.S., Illing, M.E., Bence, N.F. and Kopito, R.R. Specificity in intracellular protein aggregation and inclusion body formation. Proc. Natl. Acad. Sci. USA 98 (2001) 13060–13065. http://dx.doi.org/10.1073/pnas.18147979810.1073/pnas.181479798Search in Google Scholar PubMed PubMed Central

[20] Corboy, M.J., Thomas, P.J. and Wigley, W.C. CFTR degradation and aggregation. Methods Mol. Med. 70 (2002) 277–294. Search in Google Scholar

[21] Mukai, H., Isagawa, T., Goyama, E., Tanaka, S., Bence, N.F., Tamura, A., Ono, Y. and Kopito, R.R. Formation of morphologically similar globular aggregates from diverse aggregation-prone proteins in mammalian cells. Proc. Natl. Acad. Sci. USA 102 (2005) 10887–10892. http://dx.doi.org/10.1073/pnas.040928310210.1073/pnas.0409283102Search in Google Scholar PubMed PubMed Central

[22] Milewski, M.I., Mickle, J.E., Forrest, J.K., Stanton, B.A. and Cutting, G.R. Aggregation of misfolded proteins can be a selective process dependent upon peptide composition. J. Biol. Chem. 277 (2002) 34462–34470. http://dx.doi.org/10.1074/jbc.M20542020010.1074/jbc.M205420200Search in Google Scholar PubMed

[23] Milewski, M.I., Mickle, J.E., Forrest, J.K., Stafford, D.M., Moyer, B.D., Cheng, J., Guggino, W.B., Stanton, B.A. and Cutting, G.R. A PDZ-binding motif is essential but not sufficient to localize the C terminus of CFTR to theapical membrane. J. Cell Sci. 114 (2001) 719–726. Search in Google Scholar

[24] Zeitlin, P.L., Lu, L., Rhim, J., Cutting, G., Stetten, G., Kieffer, K.A., Craig, R. and Guggino, W.B. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am. J. Respir. Cell Mol. Biol. 4 (1991) 313–319. 10.1165/ajrcmb/4.4.313Search in Google Scholar PubMed

[25] Jiang, X., Hill, W.G., Pilewski, J.M. and Weisz, O.A. Glycosylation differences between a cystic fibrosis and rescued airway cell line are not CFTR dependent. Am. J. Physiol. 273 (1997) L913–L920. 10.1152/ajplung.1997.273.5.L913Search in Google Scholar PubMed

[26] Eudes, R., Lehn, P., Ferec, C., Mornon, J.P. and Callebaut, I. Nucleotide binding domains of human CFTR: a structural classification of critical residues and disease-causing mutations. Cell Mol. Life Sci. 62 (2005) 2112–2123. http://dx.doi.org/10.1007/s00018-005-5224-y10.1007/s00018-005-5224-ySearch in Google Scholar PubMed

[27] Moyer, B.D., Duhaime, M., Shaw, C., Denton, J., Reynolds, D., Karlson, K.H., Pfeiffer, J., Wang, S., Mickle, J.E., Milewski, M., Cutting, G.R., Guggino, W.B., Li, M. and Stanton, B.A. The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane. J. Biol. Chem. 275 (2000) 27069–27074. Search in Google Scholar

[28] Thomas, C.L. and Maule, A.J. Limitations on the use of fused green fluorescent protein to investigate structure-function relationships for the cauliflower mosaic virus movement protein. J. Gen. Virol. 81 (2000) 1851–1855. Search in Google Scholar

[29] Peters, M.F., Nucifora, F.C., Jr., Kushi, J., Seaman, H.C., Cooper, J.K., Herring, W.J., Dawson, V.L., Dawson, T.M. and Ross, C.A. Nuclear targeting of mutant Huntingtin increases toxicity. Mol. Cell Neurosci. 14 (1999) 121–128. http://dx.doi.org/10.1006/mcne.1999.077310.1006/mcne.1999.0773Search in Google Scholar PubMed

[30] Gutekunst, C.A., Li, S.H., Yi, H., Mulroy, J.S., Kuemmerle, S., Jones, R., Rye, D., Ferrante, R.J., Hersch, S.M. and Li, X.J. Nuclear and neuropil aggregates in Huntington’s disease: relationship to neuropathology. J. Neurosci. 19 (1999) 2522–2534. Search in Google Scholar

[31] Yang, W., Dunlap, J.R., Andrews, R.B. and Wetzel, R. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet. 11 (2002) 2905–2917. http://dx.doi.org/10.1093/hmg/11.23.290510.1093/hmg/11.23.2905Search in Google Scholar PubMed

[32] Schilling, G., Savonenko, A.V., Klevytska, A., Morton, J.L., Tucker, S.M., Poirier, M., Gale, A., Chan, N., Gonzales, V., Slunt, H.H., Coonfield, M.L., Jenkins, N.A., Copeland, N.G., Ross, C.A. and Borchelt, D.R. Nuclear-targeting of mutant huntingtin fragments produces Huntington’s disease-like phenotypes in transgenic mice. Hum. Mol. Genet. 13 (2004) 1599–1610. http://dx.doi.org/10.1093/hmg/ddh17510.1093/hmg/ddh175Search in Google Scholar PubMed

[33] Duennwald, M.L., Jagadish, S., Muchowski, P.J. and Lindquist, S. Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc. Natl. Acad. Sci. USA 103 (2006) 11045–11050. http://dx.doi.org/10.1073/pnas.060454710310.1073/pnas.0604547103Search in Google Scholar PubMed PubMed Central

Published Online: 2007-3-15
Published in Print: 2007-9-1

© 2007 University of Wrocław, Poland

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Scroll Up Arrow